FOXO:NYE-FOXO Technologies Inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.3687

Change

-0.41 (-52.89)%

Market Cap

N/A

Volume

0.03B

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.93 (+1.25%)

USD 10.78B
DOCS Doximity Inc

+1.07 (+2.53%)

USD 7.80B
WEAV Weave Communications Inc

+0.02 (+0.14%)

USD 1.02B
MPLN MultiPlan Corporation

+0.59 (+7.17%)

USD 0.14B
AMWL American Well Corp

+0.07 (+0.79%)

USD 0.14B
OWLT Owlet Inc

-0.06 (-1.16%)

USD 0.08B
PHR Phreesia Inc

-0.24 (-1.13%)

N/A
VEEV Veeva Systems Inc Class A

+6.94 (+3.21%)

N/A
EVH Evolent Health Inc

-0.20 (-0.81%)

N/A
TDOC Teladoc Inc

+0.07 (+0.74%)

N/A

ETFs Containing FOXO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1,053.27% 90% A- 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,053.27% 90% A- 97% N/A
Trailing 12 Months  
Capital Gain 894.34% 90% A- 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 894.34% 90% A- 97% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -36.88% 10% F N/A F
Dividend Return -36.88% 10% F N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 95.68% 30% F 9% A-
Risk Adjusted Return -38.55% 20% F 7% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector